Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$10,327,943
+$415,169 QoQ
Shares Held
40,666
+0.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.39%
of 13F equity value
Holder Rank
#1,094
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITAL CITY TRUST CO/FL holds $25,072,255 across 7 Drug Manufacturers - General names. JNJ ranks #1 (41.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
40,666 | $10,327,943 | |
| 2 | ABBV |
AbbVie Inc.
|
34,427 | $8,663,209 | |
| 3 | AMGN |
Amgen Inc
|
6,238 | $2,258,903 | |
| 4 | LLY |
ELI LILLY & Co
|
1,257 | $1,507,683 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
23,154 | $1,334,133 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,790 | $615,515 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,888 | $364,869 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,327,943 | 40,666 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $9,912,774 | 40,553 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $8,440,041 | 40,783 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $7,567,917 | 40,815 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $6,264,430 | 41,011 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $6,732,108 | 40,594 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $5,948,075 | 41,129 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $6,573,477 | 40,562 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $6,015,068 | 41,154 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,704,091 | 42,380 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $6,729,161 | 42,932 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $6,570,313 | 42,185 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $7,317,638 | 44,210 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $6,701,735 | 43,237 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $7,522,463 | 42,584 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $6,941,982 | 42,495 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $7,517,370 | 42,349 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $7,460,496 | 42,095 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $7,158,595 | 41,846 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $6,693,529 | 41,446 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $6,857,302 | 41,625 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $7,261,475 | 44,183 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $6,884,115 | 43,742 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $6,803,964 | 45,701 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $6,370,397 | 45,299 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $5,827,809 | 44,443 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||